TECH Filing
4Filing Date: Apr 7, 2026

BIO-TECHNE Corp (TECH) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0000914190-26-000067open_in_new
Total Value$39.3K
Trades7
Insiders1

Transaction Details

Bohnen Shane
SVP - General Counsel·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-2.26K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateApr 3, 2026
Footnotes ▸

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. | 2,259 restricted stock units vest on 4/3/2026. | 2,259 restricted stock units vest on 4/3/2026.

Bohnen Shane
SVP - General Counsel·Direct
Exercise · Acquire
Common Stock
Shares+2.26K
Price$0.00
Total Value$0
Shares Owned After6.64K
Transaction DateApr 3, 2026
Bohnen Shane
SVP - General Counsel·Direct
Tax W/H · Dispose
Common Stock
Shares-740
Price$53.13
Total Value$39.3K
Shares Owned After5.90K
Transaction DateApr 3, 2026
Bohnen Shane
SVP - General Counsel·Direct
Stock Option (Right to Buy)Derivative
Shares0
Price-
Total Value$0
Shares Owned After8.85K
ExpiresAug 7, 2026
Holding Only
Footnotes ▸

Fully exercisable.

Bohnen Shane
SVP - General Counsel·Direct
Restricted Stock UnitsDerivative
Shares0
Price-
Total Value$0
Shares Owned After49
Holding Only
Footnotes ▸

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. | 49 restricted stock units vest on 8/15/2026. | 49 restricted stock units vest on 8/15/2026.

Bohnen Shane
SVP - General Counsel·Direct
Performance Stock Option (Right to Buy)Derivative
Shares0
Price-
Total Value$0
Shares Owned After12.92K
Holding Only
Footnotes ▸

Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). | Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Bohnen Shane
SVP - General Counsel·Direct
Performance Restricted Stock UnitsDerivative
Shares0
Price-
Total Value$0
Shares Owned After4.80K
Holding Only
Footnotes ▸

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. | Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). | Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Post-Transaction Holdings

Bohnen Shane
SecuritySharesChange
Common Stock6.64K+1.52K (29.64%)
Performance Restricted Stock Units4.80K-
Performance Stock Option (Right to Buy)12.92K-
Restricted Stock Units0-2.26K (-100.00%)
Stock Option (Right to Buy)8.85K-
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-04-03 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BIO-TECHNE Corp (TECH) CIK: 0000842023 --- Reporting Owner --- Name: Bohnen Shane CIK: 0001969581 Role: Officer (SVP - General Counsel) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-04-03 | Code: M (Exercise of derivative) Shares: +2,259 | Price: $0.00 Shares Owned After: 6,644 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-04-03 | Code: F (Payment of exercise/tax) Shares: -740 | Price: $53.13 Total Value: $39,316.20 Shares Owned After: 5,904 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-04-03 | Code: M (Exercise of derivative) Shares: -2,259 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F4] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F5] 2,259 restricted stock units vest on 4/3/2026. [F5] 2,259 restricted stock units vest on 4/3/2026. --- Holdings --- [Holding #1] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F1] Fully exercisable. [Holding #2] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F1] Fully exercisable. [Holding #3] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F1] Fully exercisable. [Holding #4] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F2] Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024. [Holding #5] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F3] Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. [Holding #6] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F6] Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. [Holding #7] Security: Restricted Stock Units Ownership: D (Direct) Footnotes: [F4] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F7] 49 restricted stock units vest on 8/15/2026. [F7] 49 restricted stock units vest on 8/15/2026. [Holding #8] Security: Performance Restricted Stock Units Ownership: D (Direct) Footnotes: [F4] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F8] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [F8] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #9] Security: Performance Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F8] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [F8] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #10] Security: Performance Restricted Stock Units Ownership: D (Direct) Footnotes: [F4] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F9] Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [F9] Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #11] Security: Restricted Stock Units Ownership: D (Direct) Footnotes: [F4] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F10] 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. [F10] 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. [Holding #12] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F11] Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. [Holding #13] Security: Performance Restricted Stock Units Ownership: D (Direct) Footnotes: [F4] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F12] Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [F12] Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #14] Security: Restricted Stock Units Ownership: D (Direct) Footnotes: [F4] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F13] 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. [F13] 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. [Holding #15] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F14] Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. --- Footnotes (Complete Index) --- F1: Fully exercisable. F10: 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F11: Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F12: Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F13: 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F14: Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. F2: Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024. F3: Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F5: 2,259 restricted stock units vest on 4/3/2026. F6: Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F7: 49 restricted stock units vest on 8/15/2026. F8: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). --- Signature --- /s/ /s/ Shane Bohnen (2026-04-07)

keid AI analysis is for reference only and does not constitute investment advice.